Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | CuttingEdgeInfo Reports | The Changing MSL Role: Proving Value Through Performance Measurement (PH115)

The Changing MSL Role: Proving Value Through Performance Measurement (PH115)

Revolutionize your MSL teams to help drive bottom-line results:

In the past, medical science liaisons (MSLs) served a traditional role as scientific support to sales. But market realities, including fewer drug approvals and increasing regulatory demands, have led companies to put a premium on building productive relationships with key opinion leaders and supporting company objectives through medical education.

Today, MSLs are evolving into a more independent, highly strategic function. Innovative companies rely heavily on MSLs’ scientific expertise to support educational, training, research and clinical initiatives. MSLs are emerging as solutions-driven knowledge workers and as peer-level conduits to leaders in the medical community. Through MSLs, thought leaders gain access to company decision-makers in areas such as clinical development, medical affairs, and marketing.

MSLs are in a pivotal position to influence corporate strategy. Forward-thinking organizations that recognize MSLs’ shift in responsibilities and leverage the function’s scientific expertise can adapt their strategies to measure MSL performance. They are ultimately better poised for success.

This study covers these key aspects of MSL programs:

* Structure, Budgets and Staffing: This section details companies’ structuring and alignment strategies, investment levels, and headcounts.

* MSL Qualifications and Performance Measurement: This section explores the increasing educational and clinical experience required for MSL candidates. It includes compensation data. It also examines ways in which companies gauge MSL effectiveness and contributions to company goals.

* Field Force Strategies and Communication: This section outlines MSL activities and responsibilities. It also examines the connections between sales forces and MSLs in the new compliance environment and provides recommendations for integrated communications between those groups.

Companies Included in Report:

Abbott Laboratories

Allergan

Amgen

Angiotech

Baxter Healthcare

Bayer Schering

Bristol-Myers Squibb

Cangene

CORONIS Research

Cytogen

Enzon

Janssen-Cilag

Johnson & Johnson

King Pharmaceuticals

Medtronic

Myogen

Novartis

Novo Nordisk

Organon

OrthoNeutrogena

Pfizer

Sanofi-Aventis

Schering-Plough

Solvay

Valeritas

Wyeth

A small medical device company

A small pharmaceutical company

Published 2008

203 Pages

300+ Metrics

150+ Charts and Diagrams
Table of Contents
Price: $7,695.00 / €5,096.40

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions